Deerfield Management Company, L.P. (Series C) Epizyme, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

  • $4.76 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.22 - $10.44 $9.29 Million - $18.6 Million
-1,779,094 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$9.5 - $13.75 $1.33 Million - $1.93 Million
140,094 Added 8.55%
1,779,094 $18.9 Million
Q2 2018

Aug 14, 2018
BUY
$12.85 - $18.45 $8.71 Million - $12.5 Million
678,030 Added 70.56%
1,639,000 $22.2 Million
Q1 2018

May 15, 2018
SELL
$12.5 - $19.75 $606,950 - $958,981
-48,556 Reduced 4.81%
960,970 $17.1 Million
Q4 2017

Feb 14, 2018
BUY
$11.55 - $20.1 $3.57 Million - $6.21 Million
309,000 Added 44.11%
1,009,526 $12.7 Million
Q3 2017

Nov 13, 2017
BUY
$12.7 - $19.25 $8.9 Million - $13.5 Million
700,526
700,526 $13.3 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email